Outcome of Board Meeting held on 12th November, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Symbiox Investment & Trading Co. Ltd. approved the unaudited financial results for the quarter and half year ended 30th September 2025 at its meeting on 12th November 2025. For H1 FY26, Total Income stood at Rs. 69.15 lakhs compared to Rs. 106.39 lakhs in H1 FY25, showing a decline of around 35%. However, Profit After Tax for H1 FY26 rose sharply to Rs. 33.28 lakhs from Rs. 19.19 lakhs in H1 FY25, a growth of roughly 73%. The Statutory Auditor issued an unqualified Limited Review Report with no qualifications. The company also separately disclosed Related Party Transactions for H1 FY26, where most directors received NIL remuneration, with only the Company Secretary receiving Rs. 1,56,000 in salary.
Mixed signals for shareholders — top-line shrank meaningfully year-on-year but bottom-line PAT improved substantially, suggesting margin gains or one-off items. The clean auditor review and minimal related party transactions are positives. Investors should look at whether the profit growth is sustainable given the revenue decline.